Pharmaceutical Product Lifecycle Management

Pharmaceutical Product Lifecycle Management is the process of managing the entire lifecycle of a product from its conception, through design and manufacture, to service and disposal. Lifecycle Management forms the product information backbone for a company and its extended enterprise.

Related Guidance Documents

Biotechnology (1)

Knowledge Management (1)

Lifecycle Management (4)

Manufacturing Operations (1)

Process Analytical Technology (3)

Quality by Design (2)

View All

Community Discussions

Aug 18, 2023
Aug 16, 2023
Aug 15, 2023
Aug 14, 2023
Aug 09, 2023
Aug 08, 2023
Aug 07, 2023
Aug 02, 2023
Aug 02, 2023
Jul 24, 2023
Jul 19, 2023
Jul 05, 2023
Jul 05, 2023
Jul 01, 2023
Jun 26, 2023
Jun 21, 2023
Jun 21, 2023
Jun 20, 2023
Jun 15, 2023

Related Pharmaceutical Engineering Magazine Articles

Figure 1: Cleaning recipe process map.
Life-Cycle Approach to Cleaning Topical Drug Products
Topical drug products and cosmetics are often manufactured in the same facility under a unified…
Figure 1: Redundancies in the postapproval change management process contribute to delayed approval.
Streamlining Postapproval Submissions Using ICH Q12 & SCDM
Postapproval change management of pharmaceuticals is an essential part of life-cycle management but…
Reimagining CPV for a Pharma 4.0™ World
Reimagining CPV for a Pharma 4.0™ World
The life cycle approach to process validation stresses the need for continued monitoring of process…
Viral Vector Platforms: Intersection of Facility and Program
Viral Vector Platforms: Intersection of Facility and Program
Realizing the promise of any novel viral vector therapeutic depends on the innovator’s ability to…
Figure 2: Setting a risk-based CQV plan
Today’s Pharma and Biotech Projects: A Phased Approach
This article revisits the concept of phased engineering, procurement, and construction (EPC) and…
Figure 1: PQLI integration over the product life cycle.
PQLI®: Advancing Innovation & Regulation
A unique aspect of the pharmaceutical industry is the pairing of innovation and regulation. For…
A Vision for ICH Q12: Current Experience, Future Perspectives
A Vision for ICH Q12: Current Experience, Future Perspectives
Management of global postapproval chemistry, manufacturing, and controls (CMC) changes is a growing…
Navigating the Life Cycle for Cell & Gene Therapies
Navigating the Life Cycle for Cell & Gene Therapies
Cell and gene therapies are complex. As more therapies come to market in the hope of bringing…
Effect of Industry 4.0 enablers on the product life cycle.
Data Science for Pharma 4.0™: Drug Development, & Production—Part 2
This second of a two-part series explores digital transformation and digitalization in the…
IT Services: Applying Good IT Practice & Automation
IT Services: Applying Good IT Practice & Automation
This article focuses on pragmatic quality- and risk-based approaches to IT infrastructure. It covers…
Figure 1: Traditional cleaning validation approach emphasizes validating the cleaning process.
Cleaning Validation Program Maintenance in a Process Life-Cycle Model
The process life-cycle model, as discussed in the US FDA guidance on process validation, is a…
Reporting categories for changes in the drug substance (DS) and drug product (DP) process and analytical methods per FDA guidance [
Case Study: Facilitating Efficient Life-Cycle Management via ICH Q12
The latest ICH guideline, ICH Q12,International Council for Harmonisation of Technical Requirements…